IRM vs SBAC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

IRM

50.3
AI Score
VS
IRM Wins

SBAC

29.3
AI Score

Investment Advisor Scores

IRM

50score
Recommendation
BUY

SBAC

29score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric IRM SBAC Winner
Forward P/E 58.4795 19.3798 SBAC
PEG Ratio 2.701 10.7669 IRM
Revenue Growth 18.5% 2.3% IRM
Earnings Growth 860.0% -10.5% IRM
Tradestie Score 50.3/100 29.3/100 IRM
Profit Margin 5.5% 34.5% SBAC
Beta 1.00 1.00 Tie
AI Recommendation BUY AVOID NEW MONEY IRM

Relative Price Performance (Last 90 Days)

IRM 1M: -3.8% · 3M: -13.8% SBAC 1M: +4.6% · 3M: +2.8%

Current Technical Phase

IRM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.7%), weak momentum, RSI 43

RSI (14): 42.9 · Price: $110.66

SBAC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.5 · Price: $178.39

Fundamentals Snapshot

Metric IRM SBAC
Market Cap — —
Forward P/E 40.5 22.1
Trailing P/E 81.9 18.7
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.5% 0.7%
Operating Margin 0.2% 0.5%
EPS 1.40 9.27
Dividend Yield 0.03% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IRM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.